Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPGB for Postdural Puncture Headache in Obstetric Patients
NCT04515901Withdrawn
- Sponsor
- McMaster University
- Start
- Dec 2021
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of lidocaine 10% oropharyngeal spray in post-dural puncture headache (PDPH) (2 arms), sponsored by McMaster University. Primary endpoint: Enrollment rate at 6 months. Planned start Dec 2021; status: withdrawn.
02
Drugs
lidocaine 10% oropharyngeal spray
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT04515901.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04515901.